NODESINNDIANAD3. 1Patent on Fe (III) -based MRI contrast agents

Key Points

• The aim is to explore the effectiveness of iron(III) complexes with specific ligands as MRI contrast agents.
• Synthesis of 1,4-Bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives.
• Characterization of iron(III) complexes with these ligands.
• Evaluation of their efficacy as MRI contrast agents.
• Demonstrated improved contrast in MRI imaging with iron(III) complexes.
• Specific ligand modifications enhanced binding and imaging properties.

Abstract